Publication & Citation Trends
Publications
0 total
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells OA
Cited by 8
Semantic Scholar
Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update OA
Cited by 208
Semantic Scholar
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer OA
Cited by 15
Semantic Scholar
Abstract 5514: Analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients pre- and post-neoadjuvant chemotherapy for operable breast cancer
Cited by 0
Semantic Scholar
Dabrafenib and trametinib in patients with tumors with BRAF V600E/K mutations: Results from the molecular analysis for therapy choice (MATCH) Arm H.
Cited by 14
Semantic Scholar
Metastatic breast cancer patient perceptions of somatic tumor genomic testing OA
Cited by 13
Semantic Scholar
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. OA
Cited by 24
Semantic Scholar
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer OA
Cited by 68
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(11)
Cancer Treatment and Pharmacology
(10)
Cancer Cells and Metastasis
(8)
Cancer Genomics and Diagnostics
(8)
Advanced Breast Cancer Therapies
(7)
Affiliations
OhioHealth
University of Calgary
Cancer Research Institute
Riverside Methodist Hospital
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute